CClinicalTrials.gg
CompletedNCT06430281Updated Jul 22, 2025

Manual Therapy Force Perception Scale

An observational study in Manual Therapy, sponsored by Université du Québec à Trois-Rivières. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2025-07-22.

Sponsored by Université du Québec à Trois-Rivières · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
10
Sex
All
01

Study summary

The objective of this observational study is to pilot a scale designed to assist clinicians in evaluating the force they perceive during manual therapy.

The main question it aims to answer is:

- Are clinicians able to evaluate the force they use when delivering manual therapies to their patients using a scale?

For the pilot test, licensed chiropractors administer manual therapies on a manikin.

Read the detailed description

The aim of this observational study is to pilot test an ordinal scale (the Manual Therapy Force Perception [MTFP] scale) intended to enable clinicians to assign ordinal rankings to their patients based on their perception of the force they applied during manual therapy . This involved evaluating the agreement between the force applied by clinicians during spinal manipulations and mobilizations delivered on a manikin and their subjective perception of force, as determined using the MTFP scale. Additionally, the pilot study aimed to seek feedback on the MTFP scale from clinicians who are its potential users.

02

Conditions studied

  • Manual Therapy

Keywords

  • Chiropractic
  • Spinal mobilization
  • Spinal manipulation
  • force sensor
03

In context

Lead sponsor

Université du Québec à Trois-Rivières is the lead sponsor of 40 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Licensed chiropractors

Inclusion criteria

  • Licensed chiropractors with a private practice within the province of Quebec, Canada.

Exclusion criteria

Exclusion Criteria:

  • Having a condition that prevents the execution of approximately 50 manual therapies over a 1-hour period.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
10 participants (actual)
Patient registry
No

Groups and cohorts

  • Participants

    Chiropractors will administer manual therapies on a manikin utilizing three distinct levels of force (typical force, low force, high force), determined by the trial label on the scale. A sensor will gauge the magnitude of force applied.

    Other: Manual therapy

Interventions

  • OtherManual therapy

    A manual force will be applied to a manikin positioned on a chiropractic treatment table. The force exerted during the manual therapy must align with the trial label indicated on the Manual Therapy Force Perception \[MTFP\] scale.

06

What researchers measure

Primary outcomes

  1. Peak force measured by a force sensor during the manual therapy

    The therapy will be delivered on a force sensor (Loadpad(R)) which will measured the force applied. The peak force reached during the therapy will be extracted.

    Time frame: During the manual therapy

07

Study locations

1 site
  • Université du Québec à Trois-Rivières
    Trois-Rivières, Quebec G8Z 4M3, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06430281
Lead sponsor
Université du Québec à Trois-Rivières
Responsible party
Isabelle Pagé (Professor, Université du Québec à Trois-Rivières) — Principal investigator
First posted
May 28, 2024
Start date
Feb 1, 2024
Primary completion
May 31, 2024
Completion
May 31, 2024
Last update
Jul 22, 2025

Study contacts

Isabelle Pagé, DC, PhD
principal investigator · Université du Québec à Trois-Rivières

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion